Literature DB >> 25199319

[Efficacy of repeated subcostal transversus abdominis plane blocks with 0.2% lidocaine via 18-gauge intravenous catheters for patients undergoing abdominal aortic aneurism surgery].

Goh Yamamoto, Tatsunori Watanabe, Takashi Fujiwara, Takashi Mochida, Ippei Watanabe, Tatsuro Kohno.   

Abstract

BACKGROUND: There is an increasing number of patients scheduled for abdominal aortic aneurysm resection in whom epidural anesthesia cannot be performed because of concomitant antiplatelet/anticoagulant therapy. Instead of epidural anesthesia for postoperative analgesia in such patients it is possible to use repeated bilateral subcostal transversus abdominis plane (TAP) blocks.
METHODS: Four patients receiving antiplatelet/anticoagulant therapy for abdominal aortic aneurysm resection under general anesthesia were studied. After the completion of surgery and before emergence from anesthesia 18-gauge intravenous catheters were inserted bilaterally into subcostal TAP and 100 ml (50 ml on each side) of 0.2% lidocaine with 1/500,000 epinephrine were injected via the catheters twice daily until the second postoperative day. Pain intensity was assessed using a 0-10 numerical rating scale at rest and during movement, before and after each block.
RESULTS: Numerical pain ratings at rest and during movement decreased after each block, and good analgesia was obtained. No complications such as nausea, vomiting or infection were observed in the postoperative period.
CONCLUSIONS: These findings suggest that repeated bilateral subcostal TAP blocks with 0.2% lidocaine performed via 18-gauge intravenous catheters provide good postoperative analgesia after abdominal aortic aneurysm resection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199319

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  1 in total

1.  Analgesic efficacy of ultrasound-guided subcostal transversus abdominis plane block.

Authors:  Jianfeng Ma; Yifei Jiang; Shiyi Tang; Benfu Wang; Qingquan Lian; Zuokai Xie; Jun Li
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.